
AI Convergence: Small Molecule Discovery Summit 2026
Beschrijving
The AI Convergence: Small Molecule Discovery Summit is an essential gathering for industry leaders and innovators at the forefront of AI and medicinal chemistry. This summit emphasizes the transformative potential of AI and machine learning (AI/ML) in accelerating the design and optimization of small molecules aimed at challenging drug targets.
Hoogtepunten
22 world-class AI/ML-guided small molecule discovery speakers. 2 days of exclusive content addressing AI/ML methods, applications, tool convergence, and confidence. Unmatched networking and strategic partnering opportunities. Focused industry-led community of top techbio, pharma, and biotech companies. Explore AI/ML applications that elucidate undruggable target protein folding. Leverage AI/ML-enabled virtual screening to tap into unexplored chemical space. Use generative molecular design for molecular glues, covalent inhibitors, and degraders. Optimize ADME-T and address data input and federated learning platform opportunities. Join industry leaders such as Insilico Medicine, PsiThera, OpenADMET, Sanofi, and Novo Nordisk. Discover the convergence of state-of-the-art AI/ML tools with existing approaches to ignite future AI/ML-enabled small molecule discovery.
Locatie evenement
Laat je netwerk weten dat je komt
Deel dit evenement om gesprekken te starten, collega`s uit te nodigen en van tevoren contact te leggen.
Ontmoet de sprekers

Alexander Hillisch
Thema:Head, Digital Molecule Discovery & Executive Director

Devany West
Thema:Software Scientist

Hannes Stark
Thema:PhD Student, MIT, Boltz Team

Hariprasad Vankayalapati
Thema:Chief Scientific Officer, Biolexis Therapeutics

Henry van den Bedem
Thema:Chief Technology Officer
